Clinical Use of Serum c-erbB-2 in Patients with Ovarian Masses

Publisher： Karger

E-ISSN： 1423-002x|48|2|133-137

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.48, Iss.2, 1999-08, pp. : 133-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Characteristics of Patients in Japan with Ovarian Cancer Presumably Arising from Ovarian Endometrioma

By  

Gynecologic and Obstetric Investigation, Vol. 77, Iss. 2, 2014-02 ,pp. : 104-110

Karger

Access to resources Recommend Favorite

Serum Estradiol Levels after 4 Days of Ovarian Hyperstimulation in Oocyte Donors Are Predictive of Embryo Quality and Clinical Outcomes

By  

Gynecologic and Obstetric Investigation, Vol. 54, Iss. 4, 2003-02 ,pp. : 207-212

Karger

Access to resources Recommend Favorite

Clinical Value of Basal Serum Progesterone Prior to Initiate Ovarian Hyper-Stimulation with GnRH Antagonists: A Retrospective Cohort Study

By  

Gynecologic and Obstetric Investigation, Vol. 82, Iss. 2, 2016-08 ,pp. : 175-180

Karger

Access to resources Recommend Favorite

Three-Dimensional Angioultrasonography for the Prediction of Malignancy in Ovarian Masses

By  

Gynecologic and Obstetric Investigation, Vol. 75, Iss. 2, 2013-01 ,pp. : 120-125

Karger

Access to resources Recommend Favorite

Prognostic Significance of Serum Soluble CD163 Level in Patients with Epithelial Ovarian Cancer

By  

Gynecologic and Obstetric Investigation, Vol. 75, Iss. 4, 2013-04 ,pp. : 263-267

Karger

Access to resources Recommend Favorite